Literature DB >> 17088454

Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction.

Martin S Maron1, Iacopo Olivotto, Andrey G Zenovich, Mark S Link, Natesa G Pandian, Jeffery T Kuvin, Stefano Nistri, Franco Cecchi, James E Udelson, Barry J Maron.   

Abstract

BACKGROUND: Nonobstructive hypertrophic cardiomyopathy (HCM) has been regarded as the predominant hemodynamic form of the disease on the basis of assessment of outflow gradient under resting conditions. We sought to prospectively define the prevalence, clinical profile, and significance of left ventricular (LV) outflow tract obstruction under resting conditions and with physiological exercise in a large HCM cohort. METHODS AND
RESULTS: We prospectively analyzed 320 consecutive HCM patients (age, 47+/-17 years), measuring LV outflow gradient at rest, with Valsalva maneuver, and with exercise echocardiography. LV outflow obstruction was present at rest and/or with exercise in 225 patients (70%); 119 had rest gradients > or = 50 mm Hg and were not exercised. Of the other 201 patients with gradients < 50 mm Hg at rest (average, 4+/-9 mm Hg), 106 developed mechanical obstruction to LV outflow resulting from mitral valve-septal contact after exercise (80+/-43 mm Hg), including 76 with marked gradients > or = 50 mm Hg and 46 with heart failure symptoms. The remaining 95 patients (30%) had no or small gradients (< 30 mm Hg) both at rest and with exercise. Valsalva maneuver underestimated the presence and magnitude of exercise-induced obstruction.
CONCLUSIONS: Among those patients who come to clinical evaluation, HCM is a predominantly obstructive disease in which LV outflow gradients, frequently associated with heart failure symptoms and often identified only with exercise, are evident in most patients (ie, 70%). Identification of LV outflow obstruction with exercise echocardiography may broaden management options in HCM by identifying symptomatic patients not otherwise regarded as potential candidates for septal reduction therapy. Assessment of subaortic gradients with exercise should be a routine component of the evaluation of HCM patients without outflow obstruction under resting conditions.

Entities:  

Mesh:

Year:  2006        PMID: 17088454     DOI: 10.1161/CIRCULATIONAHA.106.644682

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  171 in total

1.  Cardiomyopathy of Friedreich's ataxia (FRDA).

Authors:  R M Payne; R E Peverill
Journal:  Ir J Med Sci       Date:  2012-02-29       Impact factor: 1.568

2.  Echocardiography in stress cardiomyopathy and acute LVOT obstruction.

Authors:  Anand Chockalingam; Gong-Yuan Xie; Kevin C Dellsperger
Journal:  Int J Cardiovasc Imaging       Date:  2010-02-02       Impact factor: 2.357

3.  Exercise in hypertrophic cardiomyopathy.

Authors:  Sharlene M Day
Journal:  J Cardiovasc Transl Res       Date:  2009-10-14       Impact factor: 4.132

Review 4.  Hypertrophic cardiomyopathy.

Authors:  Carolyn Y Ho
Journal:  Heart Fail Clin       Date:  2010-04       Impact factor: 3.179

Review 5.  The left ventricular outflow in hypertrophic cardiomyopathy: from structure to function.

Authors:  Magdi H Yacoub; Ismail El-Hamamsy; Karim Said; Gehan Magdi; Fatma Abul Enein; Robert George; Alessandra Rossi; Iacopo Olivotto; Franco Cecchi
Journal:  J Cardiovasc Transl Res       Date:  2009-11-26       Impact factor: 4.132

Review 6.  Mitral valve disease--morphology and mechanisms.

Authors:  Robert A Levine; Albert A Hagége; Daniel P Judge; Muralidhar Padala; Jacob P Dal-Bianco; Elena Aikawa; Jonathan Beaudoin; Joyce Bischoff; Nabila Bouatia-Naji; Patrick Bruneval; Jonathan T Butcher; Alain Carpentier; Miguel Chaput; Adrian H Chester; Catherine Clusel; Francesca N Delling; Harry C Dietz; Christian Dina; Ronen Durst; Leticia Fernandez-Friera; Mark D Handschumacher; Morten O Jensen; Xavier P Jeunemaitre; Hervé Le Marec; Thierry Le Tourneau; Roger R Markwald; Jean Mérot; Emmanuel Messas; David P Milan; Tui Neri; Russell A Norris; David Peal; Maelle Perrocheau; Vincent Probst; Michael Pucéat; Nadia Rosenthal; Jorge Solis; Jean-Jacques Schott; Ehud Schwammenthal; Susan A Slaugenhaupt; Jae-Kwan Song; Magdi H Yacoub
Journal:  Nat Rev Cardiol       Date:  2015-10-20       Impact factor: 32.419

7.  Relation of pulse pressure to blood pressure response to exercise in patients with hypertrophic cardiomyopathy.

Authors:  Kevin S Heffernan; Martin S Maron; Eshan A Patvardhan; Richard H Karas; Jeffrey T Kuvin
Journal:  Am J Cardiol       Date:  2010-12-22       Impact factor: 2.778

Review 8.  Transcatheter septal ablation in hypertrophic obstructive cardiomyopathy: a technical guide and review of published results.

Authors:  Angelos G Rigopoulos; Stefanos Sakellaropoulos; Muhammad Ali; Sophie Mavrogeni; Athanassios Manginas; Matthias Pauschinger; Michel Noutsias
Journal:  Heart Fail Rev       Date:  2018-11       Impact factor: 4.214

Review 9.  Principles of transthoracic echocardiographic evaluation.

Authors:  Anita C Boyd; Nelson B Schiller; Liza Thomas
Journal:  Nat Rev Cardiol       Date:  2015-04-28       Impact factor: 32.419

Review 10.  Athlete's heart or hypertrophic cardiomyopathy?

Authors:  Jörg Lauschke; Bernhard Maisch
Journal:  Clin Res Cardiol       Date:  2008-10-13       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.